Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 101

1.

Androgen receptor enhances cell adhesion and decreases cell migration via modulating β1-integrin-AKT signaling in hepatocellular carcinoma cells.

Ma WL, Jeng LB, Lai HC, Liao PY, Chang C.

Cancer Lett. 2014 Aug 28;351(1):64-71. doi: 10.1016/j.canlet.2014.05.017. Epub 2014 Jun 4.

PMID:
24944078
[PubMed - indexed for MEDLINE]
2.

Chem-seq permits identification of genomic targets of drugs against androgen receptor regulation selected by functional phenotypic screens.

Jin C, Yang L, Xie M, Lin C, Merkurjev D, Yang JC, Tanasa B, Oh S, Zhang J, Ohgi KA, Zhou H, Li W, Evans CP, Ding S, Rosenfeld MG.

Proc Natl Acad Sci U S A. 2014 Jun 24;111(25):9235-40. doi: 10.1073/pnas.1404303111. Epub 2014 Jun 13.

PMID:
24928520
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Androgen receptor (AR) suppresses normal human prostate epithelial cell proliferation via AR/β-catenin/TCF-4 complex inhibition of c-MYC transcription.

Antony L, van der Schoor F, Dalrymple SL, Isaacs JT.

Prostate. 2014 Aug;74(11):1118-31. doi: 10.1002/pros.22828. Epub 2014 Jun 9.

PMID:
24913829
[PubMed - indexed for MEDLINE]
4.

A novel androgen receptor gene mutation in a patient with congenital adrenal hyperplasia associated with penoscrotal hypospadias.

Sharma V, Thangaraj K, Jyothy A.

Transl Res. 2014 Aug;164(2):149-52. doi: 10.1016/j.trsl.2014.03.013. Epub 2014 May 6.

PMID:
24907477
[PubMed - indexed for MEDLINE]
5.

Androgen receptor CAG repeat length and TMPRSS2:ETS prostate cancer risk: results From the Prostate Cancer Prevention Trial.

Figg WD, Chau CH, Price DK, Till C, Goodman PJ, Cho Y, Varella-Garcia M, Reichardt JK, Tangen CM, Leach RJ, van Bokhoven A, Thompson IM, Lucia MS.

Urology. 2014 Jul;84(1):127-31. doi: 10.1016/j.urology.2014.03.015. Epub 2014 May 10.

PMID:
24824408
[PubMed - indexed for MEDLINE]
6.

Enhancer RNAs participate in androgen receptor-driven looping that selectively enhances gene activation.

Hsieh CL, Fei T, Chen Y, Li T, Gao Y, Wang X, Sun T, Sweeney CJ, Lee GS, Chen S, Balk SP, Liu XS, Brown M, Kantoff PW.

Proc Natl Acad Sci U S A. 2014 May 20;111(20):7319-24. doi: 10.1073/pnas.1324151111. Epub 2014 Apr 28.

PMID:
24778216
[PubMed - indexed for MEDLINE]
7.

The ETS family member GABPα modulates androgen receptor signalling and mediates an aggressive phenotype in prostate cancer.

Sharma NL, Massie CE, Butter F, Mann M, Bon H, Ramos-Montoya A, Menon S, Stark R, Lamb AD, Scott HE, Warren AY, Neal DE, Mills IG.

Nucleic Acids Res. 2014;42(10):6256-69. doi: 10.1093/nar/gku281. Epub 2014 Apr 21.

PMID:
24753418
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Treatment of high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in adolescents and adults according to early cytologic response and minimal residual disease after consolidation assessed by flow cytometry: final results of the PETHEMA ALL-AR-03 trial.

Ribera JM, Oriol A, Morgades M, Montesinos P, Sarrà J, González-Campos J, Brunet S, Tormo M, Fernández-Abellán P, Guàrdia R, Bernal MT, Esteve J, Barba P, Moreno MJ, Bermúdez A, Cladera A, Escoda L, García-Boyero R, Del Potro E, Bergua J, Amigo ML, Grande C, Rabuñal MJ, Hernández-Rivas JM, Feliu E.

J Clin Oncol. 2014 May 20;32(15):1595-604. doi: 10.1200/JCO.2013.52.2425. Epub 2014 Apr 21.

PMID:
24752047
[PubMed - indexed for MEDLINE]
9.

Re: lncRNA-dependent mechanisms of androgen-receptor-regulated gene activation programs.

Atala A.

J Urol. 2014 May;191(5):1470-1. doi: 10.1016/j.juro.2014.02.011. Epub 2014 Feb 20. No abstract available.

PMID:
24745541
[PubMed - indexed for MEDLINE]
10.

Muscle expression of mutant androgen receptor accounts for systemic and motor neuron disease phenotypes in spinal and bulbar muscular atrophy.

Cortes CJ, Ling SC, Guo LT, Hung G, Tsunemi T, Ly L, Tokunaga S, Lopez E, Sopher BL, Bennett CF, Shelton GD, Cleveland DW, La Spada AR.

Neuron. 2014 Apr 16;82(2):295-307. doi: 10.1016/j.neuron.2014.03.001.

PMID:
24742458
[PubMed - indexed for MEDLINE]
11.

Activated androgen receptor promotes bladder cancer metastasis via Slug mediated epithelial-mesenchymal transition.

Jing Y, Cui D, Guo W, Jiang J, Jiang B, Lu Y, Zhao W, Wang X, Jiang Q, Han B, Xia S.

Cancer Lett. 2014 Jun 28;348(1-2):135-45. doi: 10.1016/j.canlet.2014.03.018. Epub 2014 Mar 21.

PMID:
24662746
[PubMed - indexed for MEDLINE]
12.

Tissue transglutaminase expression promotes castration-resistant phenotype and transcriptional repression of androgen receptor.

Han AL, Kumar S, Fok JY, Tyagi AK, Mehta K.

Eur J Cancer. 2014 Jun;50(9):1685-96. doi: 10.1016/j.ejca.2014.02.014. Epub 2014 Mar 20.

PMID:
24656569
[PubMed - indexed for MEDLINE]
13.

Differential effects of RUNX2 on the androgen receptor in prostate cancer: synergistic stimulation of a gene set exemplified by SNAI2 and subsequent invasiveness.

Little GH, Baniwal SK, Adisetiyo H, Groshen S, Chimge NO, Kim SY, Khalid O, Hawes D, Jones JO, Pinski J, Schones DE, Frenkel B.

Cancer Res. 2014 May 15;74(10):2857-68. doi: 10.1158/0008-5472.CAN-13-2003. Epub 2014 Mar 19.

PMID:
24648349
[PubMed - indexed for MEDLINE]
14.

Spatial abilities are not related to testosterone levels and variation in the androgen receptor in healthy young men.

Kubranská A, Lakatošová S, Schmidtová E, Durdiaková J, Celec P, Ostatníková D.

Gen Physiol Biophys. 2014;33(3):311-9. doi: 10.4149/gpb_2014005. Epub 2014 Mar 5.

PMID:
24595847
[PubMed - indexed for MEDLINE]
15.

FOXM1 and androgen receptor co-regulate CDC6 gene transcription and DNA replication in prostate cancer cells.

Liu Y, Gong Z, Sun L, Li X.

Biochim Biophys Acta. 2014;1839(4):297-305. doi: 10.1016/j.bbagrm.2014.02.016. Epub 2014 Feb 27.

PMID:
24583551
[PubMed - indexed for MEDLINE]
16.

Involvement of androgen receptor and glucose-regulated protein 78 kDa in human hepatocarcinogenesis.

Jiang X, Kanda T, Nakamoto S, Miyamura T, Wu S, Yokosuka O.

Exp Cell Res. 2014 May 1;323(2):326-36. doi: 10.1016/j.yexcr.2014.02.017. Epub 2014 Feb 26.

PMID:
24583399
[PubMed - indexed for MEDLINE]
17.

Maintaining and reprogramming genomic androgen receptor activity in prostate cancer.

Mills IG.

Nat Rev Cancer. 2014 Mar;14(3):187-98. doi: 10.1038/nrc3678. Review. Erratum in: Nat Rev Cancer. 2014 May;14(5). doi: 10.1038/nrc3722.

PMID:
24561445
[PubMed - indexed for MEDLINE]
18.

Androgen receptor splice variants determine taxane sensitivity in prostate cancer.

Thadani-Mulero M, Portella L, Sun S, Sung M, Matov A, Vessella RL, Corey E, Nanus DM, Plymate SR, Giannakakou P.

Cancer Res. 2014 Apr 15;74(8):2270-82. doi: 10.1158/0008-5472.CAN-13-2876. Epub 2014 Feb 20.

PMID:
24556717
[PubMed - indexed for MEDLINE]
19.

Coregulator control of androgen receptor action by a novel nuclear receptor-binding motif.

Jehle K, Cato L, Neeb A, Muhle-Goll C, Jung N, Smith EW, Buzon V, Carbó LR, Estébanez-Perpiñá E, Schmitz K, Fruk L, Luy B, Chen Y, Cox MB, Bräse S, Brown M, Cato AC.

J Biol Chem. 2014 Mar 28;289(13):8839-51. doi: 10.1074/jbc.M113.534859. Epub 2014 Feb 12.

PMID:
24523409
[PubMed - indexed for MEDLINE]
20.

Focal amplification of the androgen receptor gene in hormone-naive human prostate cancer.

Merson S, Yang ZH, Brewer D, Olmos D, Eichholz A, McCarthy F, Fisher G, Kovacs G, Berney DM, Foster CS, Møller H, Scardino P, Cuzick J, Cooper CS, Clark JP; Transatlantic Prostate Group.

Br J Cancer. 2014 Mar 18;110(6):1655-62. doi: 10.1038/bjc.2014.13. Epub 2014 Jan 30.

PMID:
24481405
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk